Cytotoxicity testing of a new caprolactone-coated self-expanding bioabsorbable self-reinforced poly-L-lactic acid urethral stent

Urological Research

Volumn 27, Issue 2, 1999, Pages 149-152

  Isotalo, Taina ^a   Talja, Martti ^b   Tammela, Teuvo L J ^a   Törmälä, Pertti ^b   Paasimaa, Senja ^b   Andersson, Leif ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Biocompatibility; Bioresorbable urethral stents; DNA synthesis inhibition test; Thymidine incorporation method; Urethral stricture

Indexed keywords

BIOMATERIAL; COPOLYMER; HEXANOIC ACID DERIVATIVE; LACTIC ACID; POLYLACTIC ACID;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; MATERIAL STATE; PRIORITY JOURNAL; STENT; TOXICITY TESTING; URETHRA DISEASE; URETHRA STRICTURE;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; POLYESTERS; STENTS; TOXICITY TESTS; URETHRA; URETHRAL OBSTRUCTION;

EID: 0032962685     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050101     Document Type: Article

References (17)

1. Ashken MH, Coulange C, Milroy E, Sarramon J (1991) European experience with the urethral Wallstent for urethral strictures. Eur Urol 19:181
2. Baert L, Verhamme L, van Poppel H, Vandeursen H, Baert J (1993) Long-term consequences of urethral stents. J Urol 150:853
3. Biological evaluation of medical devices, part I (1995) Evaluation and testing. International Standard ISO 10993
4. Chilton CP, Shah PJR, Fowler CG, Tiptaft RC, Blandy JP (1983) The impact of optical urethrotomy on the management of urethral strictures. Br J Urol 55:705
5. Dahlstrand C, Grundtman S, Pettersson S (1996) High energy TUMT and the use of resorbable stem for large benign prostatic hyperplasia. XIIth Congress of the Association of Urology, 1-4 September 1996, Paris. Eur Urol 30 (Suppl 2): abstract 975
6. Hiljanen-Vainio MP, Orava PA, Seppälä JV (1997) Properties of ε-caprolactone/DL-lactide (ε-CL/DL-LA) copolymers with a minor ε-CL content. J Biomed Mater Res 34:39
7. Holm-Nielsen A, Shulz A, Möller-Pedersen V (1991) Direct vision internal urethrotomy: a critical review of 365 operations. Br J Urol 56:308
8. Kemppainen E, Talja M, Riihelä M, Pohjonen T, Törmälii P, Alfthan O (1993) A bioresorbable urethral stent; an experimental study. Urol Res 21:235
9. Milroy E, Cooper J, Wallsten H, Chapple R, Eldin A, Seddon A (1988) A new treatment for urethral strictures. Lancet I:1424
10. Pitkämäki KK, Tammela TLJ, Kontturi MJ (1992) Recurrence of urethral stricture and late results after optical urethrotomy: comparison of strictures caused by toxic latex catheters and other causes. Scand J Urol Nephrol 26:327
11. Rokkanen P, Böstman O, Hirvensalo E, Partio E, Vihtonen K, Vainionpää S, Mäkelä A, Törmälä P (1992) The use of absorbable internal fracture fixation devices. Adv Biomater 10:447
12. Rosenbluth GE, Weddington GR, Gness WL, Antian J (1965) Tissue culture methods for screening toxicity of plastic materials to be used in medical practice. J Pharm Sci 54:156
13. Ruutu M, Alfthan O, Standentskjöld-Nordenstam CG, Lehtonen T (1983) Treatment of urethral stricture by urethroplasty or direct vision urethrotomy. Scand J Urol Nephrol 17:1
14. Ruutu M, Alfthan O, Talja M, Andersson L (1985) Cytotoxicity of latex urinary catheters. Br J Urol 57:82
15. Sachse H (1974) Zur behandlung der harnröhrenstriktur: die transurethrale schlitzung unter sicht mit scharfem schnitt. Fortschr Med 92:12
16. Talja M, Andersson L, Ruutu M, Alfthan O (1985) Toxicity testing of urinary catheters. Br J Urol 57:579
17. Talja M, Tammela T, Petas A, Välimaa T, Taari K, Viherkoski E, Törmälä P (1995) Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate laser prostatectomy. J Urol 154:2089